Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jincaopian Tablets for Chronic Pelvic Pain After PID
NCT05460546Phase 2Completed
- Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Start
- Jan 2021
- Primary completion
- Nov 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of jincaopian in chronic pelvic pain (CPP), sponsored by Beijing Konruns Pharmaceutical Co., Ltd.. Started Jan 2021; status: completed.
02
Drugs
jincaopian
03
Conditions
chronic pelvic pain (CPP)
Beyond the preview
Go deeper on NCT05460546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05460546.